Improving healing of delayed fractures using a new bone growth agent
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union
This study is testing a new gel treatment that helps broken bones heal faster, especially for people who have trouble with healing due to certain health issues or medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11010026 on NIH RePORTER |
What this research studies
This research focuses on enhancing the healing process of fractures that are slow to heal or do not heal properly, which affects many individuals, especially those with certain health conditions or who use specific medications. The approach involves a novel polymeric prodrug that delivers a bone anabolic agent directly to the fracture site, promoting faster healing. Patients will receive this treatment in a form that becomes a gel at body temperature, allowing for localized and effective delivery of the healing agent. The study aims to address a significant gap in current treatment options for delayed fracture healing.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with delayed fracture healing, particularly those with risk factors such as diabetes or those who have been treated with glucocorticoids.
Not a fit: Patients with fractures that are healing normally or those who do not have any underlying health conditions affecting healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce healing time for patients with delayed fractures, improving their mobility and quality of life.
How similar studies have performed: Previous research has shown promise in using localized delivery systems for bone healing, indicating that this approach may be effective.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Wang, Dong — University of Nebraska Medical Center
- Study coordinator: Wang, Dong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.